awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34642865-46E42C21-46F8-4EC6-8AB8-705BE6E4D179
Q34642865-46E42C21-46F8-4EC6-8AB8-705BE6E4D179
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34642865-46E42C21-46F8-4EC6-8AB8-705BE6E4D179
Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P2860
Q34642865-46E42C21-46F8-4EC6-8AB8-705BE6E4D179
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34642865-46E42C21-46F8-4EC6-8AB8-705BE6E4D179
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d19ce85bb23f4c461e4469fd41ed459d1ba56a2
P2860
Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results